Drug Pipeline

TAR-200 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
0
Recruiting
3
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
3
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04658862 A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in… Urinary Bladder Neoplasms Active, Not Recruiting
NCT05714202 A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical… Bladder Cancer Active, Not Recruiting
NCT06211764 A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent… Non-Muscle Invasive Bladder Neoplasms Active, Not Recruiting
Phase 2
NCT04919512 A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants… Urinary Bladder Neoplasms Active, Not Recruiting
NCT04640623 A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in… Urinary Bladder Neoplasms Active, Not Recruiting
Sponsors Running TAR-200 Trials
Disease Areas
Get alerts when TAR-200 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free